Wijewardhane N(1), Dressler L(2), Ciccarelli FD(3). Author information:
(1)Cancer Systems Biology Laboratory, The Francis Crick Institute, London NW1
1AT, UK; School of Cancer and Pharmaceutical Sciences, King's College London,
London SE1 1UL, UK.
(2)Cancer Systems Biology Laboratory, The Francis Crick Institute, London NW1
1AT, UK; School of Cancer and Pharmaceutical Sciences, King's College London,
London SE1 1UL, UK; Department of Medical and Molecular Genetics, King's College
London, London WC2R 2LS, UK.
(3)Cancer Systems Biology Laboratory, The Francis Crick Institute, London NW1
1AT, UK; School of Cancer and Pharmaceutical Sciences, King's College London,
London SE1 1UL, UK. Electronic address: [Email]
Gene alterations play a prominent role in driving cancer initiation and progression. However, the genetic events that occur in normal cells prior to tumorigenesis are still unknown. Recent studies have started to map somatic mutations in normal human tissues, and here we discuss their implications for our understanding of tumorigenesis.
OUR JOURNALS
Having over 250 Research scholars worldwide and more than 400 articles online with open access.
